中国医院用药评价与分析
中國醫院用藥評價與分析
중국의원용약평개여분석
EVALUATION AND ANAL YSIS OF DRUG-USE IN HOSPITALS OF CHINA
2015年
4期
457-459
,共3页
慢性黄疸型肝炎%天门冬氨酸鸟氨酸%天门冬氨酸钾镁
慢性黃疸型肝炎%天門鼕氨痠鳥氨痠%天門鼕氨痠鉀鎂
만성황달형간염%천문동안산조안산%천문동안산갑미
Chronic icteric hepatitis%Ornithine Aspartate%Potassium magnesium aspartata
目的:探讨天门冬氨酸鸟氨酸对慢性黄疸型肝炎肝功能指标降低情况及临床效果。方法:将广州市番禺区中医院2011年3月至2013年7月收治的146例慢性肝炎患者随机分为对照组和治疗组,每组73例,分别给予天门冬氨酸钾镁对照组和天门冬氨酸鸟氨酸治疗组进行治疗。比较两组的临床疗效和肝功能指标。结果:两组均有治疗效果,治疗组治疗后血清总胆红素(TBIL)、碱性磷酸酶(ALP)、丙氨酸氨基转移酶(ALT)、γ-谷氨酰转移酶(γ-GT)和天门冬氨酸氨基转移酶(AST)较对照组有显著降低( P<0.05)。结论:天门冬氨酸鸟氨酸治疗慢性黄疸型肝炎的临床疗效显著,在降低肝功能指标上作用显著,值得临床推广。
目的:探討天門鼕氨痠鳥氨痠對慢性黃疸型肝炎肝功能指標降低情況及臨床效果。方法:將廣州市番禺區中醫院2011年3月至2013年7月收治的146例慢性肝炎患者隨機分為對照組和治療組,每組73例,分彆給予天門鼕氨痠鉀鎂對照組和天門鼕氨痠鳥氨痠治療組進行治療。比較兩組的臨床療效和肝功能指標。結果:兩組均有治療效果,治療組治療後血清總膽紅素(TBIL)、堿性燐痠酶(ALP)、丙氨痠氨基轉移酶(ALT)、γ-穀氨酰轉移酶(γ-GT)和天門鼕氨痠氨基轉移酶(AST)較對照組有顯著降低( P<0.05)。結論:天門鼕氨痠鳥氨痠治療慢性黃疸型肝炎的臨床療效顯著,在降低肝功能指標上作用顯著,值得臨床推廣。
목적:탐토천문동안산조안산대만성황달형간염간공능지표강저정황급림상효과。방법:장엄주시번우구중의원2011년3월지2013년7월수치적146례만성간염환자수궤분위대조조화치료조,매조73례,분별급여천문동안산갑미대조조화천문동안산조안산치료조진행치료。비교량조적림상료효화간공능지표。결과:량조균유치료효과,치료조치료후혈청총담홍소(TBIL)、감성린산매(ALP)、병안산안기전이매(ALT)、γ-곡안선전이매(γ-GT)화천문동안산안기전이매(AST)교대조조유현저강저( P<0.05)。결론:천문동안산조안산치료만성황달형간염적림상료효현저,재강저간공능지표상작용현저,치득림상추엄。
OBJECTIVE:To evaluate the clinical efficacy of ornithine aspartate to reduce liver function index in patients with chronic icteric hepatitis.METHODS:146 patients with chronic hepatitis treated in our hospital from Mar. 2011 to July 2013 were randomly assigned to either control group treated with potassium magnesium aspartate or treatment group treated with aspartate ornithine, 73 cases each group.The clinical efficacy and the liver functional index in the two groups were compared.RESULTS:Both groups showed clinical response to treatment.The treatment group showed significantly greater reduction in serum total bilirubin ( TBIL ) , alkaline phosphatase ( ALP ) , serum alanine aminotransferase (ALT),γ-glutamyl transferase(γ-GT) and aspartate aminotransferase (AST) than in the control group ( P<0.05 ) .CONCLUSION:Ornithine aspartate therapy shows remarkable efficacy in terms of reduction of liver functional indexes in patients with chronic icteric hepatitis, which is thus worthy of clinical promotion.